BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 30927058)

  • 1. A New Diagnosis-Specific Survival Score for Patients to be Irradiated for Brain Metastases from Non-small Cell Lung Cancer.
    Rades D; Hansen HC; Schild SE; Janssen S
    Lung; 2019 Jun; 197(3):321-326. PubMed ID: 30927058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new instrument for predicting survival of patients with cerebral metastases from breast cancer developed in a homogeneously treated cohort.
    Janssen S; Hansen HC; Dziggel L; Schild SE; Rades D
    Radiol Oncol; 2019 May; 53(2):219-224. PubMed ID: 31103998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial.
    Churilla TM; Ballman KV; Brown PD; Twohy EL; Jaeckle K; Farace E; Cerhan JH; Anderson SK; Carrero XW; Garces YI; Barker FG; Deming R; Dixon JG; Burri SH; Chung C; Ménard C; Stieber VW; Pollock BE; Galanis E; Buckner JC; Asher AL
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1173-1178. PubMed ID: 28939223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial.
    Aoyama H; Tago M; Shirato H;
    JAMA Oncol; 2015 Jul; 1(4):457-64. PubMed ID: 26181254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
    Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
    J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients.
    Rades D; Schild SE; Lohynska R; Veninga T; Stalpers LJ; Dunst J
    Cancer; 2007 Sep; 110(5):1077-82. PubMed ID: 17614294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer.
    Kaul D; Angelidis A; Budach V; Ghadjar P; Kufeld M; Badakhshi H
    Radiat Oncol; 2015 Nov; 10():244. PubMed ID: 26611493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-brain radiotherapy plus sequential or simultaneous integrated boost for the treatment of a limited number of brain metastases in non-small cell lung cancer: A single-institution study.
    Qing D; Zhao B; Zhou YC; Zhu HL; Ma DY
    Cancer Med; 2020 Jan; 9(1):238-246. PubMed ID: 31749325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC).
    Bohlen G; Meyners T; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Rades D
    Clin Neurol Neurosurg; 2010 Apr; 112(3):183-7. PubMed ID: 19962229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic radiosurgery plus whole-brain radiotherapy for treatment of multiple metastases from non-small cell lung cancer.
    Minniti G; Salvati M; Muni R; Lanzetta G; Osti MF; Clarke E; Costa A; Bozzao A; Trasimeni G; Enrici RM
    Anticancer Res; 2010 Jul; 30(7):3055-61. PubMed ID: 20683055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypofractionated whole-brain radiotherapy for multiple brain metastases from transitional cell carcinoma of the bladder.
    Rades D; Meyners T; Veninga T; Stalpers LJ; Schild SE
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):404-8. PubMed ID: 20171794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shorter-course whole-brain radiotherapy for brain metastases in elderly patients.
    Rades D; Evers JN; Veninga T; Stalpers LJ; Lohynska R; Schild SE
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e469-73. PubMed ID: 21477949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Diagnosis-Specific Survival Scores for Patients with Small-Cell Lung Cancer Irradiated for Brain Metastases.
    Rades D; Hansen HC; Janssen S; Schild SE
    Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30781513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial.
    Mulvenna P; Nankivell M; Barton R; Faivre-Finn C; Wilson P; McColl E; Moore B; Brisbane I; Ardron D; Holt T; Morgan S; Lee C; Waite K; Bayman N; Pugh C; Sydes B; Stephens R; Parmar MK; Langley RE
    Lancet; 2016 Oct; 388(10055):2004-2014. PubMed ID: 27604504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient selection for whole brain radiotherapy (WBRT) in a large lung cancer cohort: Impact of a new Dutch guideline on brain metastases.
    Hendriks LE; Troost EG; Steward A; Bootsma GP; De Jaeger K; van den Borne BE; Dingemans AM
    Acta Oncol; 2014 Jul; 53(7):945-51. PubMed ID: 24754845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
    Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
    Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis-specific WBRT-30-CRC Score for Estimating Survival of Patients Irradiated for Brain Metastases from Colorectal Cancer.
    Rades D; Hansen HC; Janssen S; Schild SE
    Anticancer Res; 2019 May; 39(5):2569-2574. PubMed ID: 31092454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors affecting survival after whole brain radiotherapy in patients with brain metastasized lung cancer.
    Tsakonas G; Hellman F; Gubanski M; Friesland S; Tendler S; Lewensohn R; Ekman S; de Petris L
    Acta Oncol; 2018 Feb; 57(2):231-238. PubMed ID: 28984492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.